Literature DB >> 28711979

Acute kidney injury and critical limb ischaemia associated with the use of the so called "legal high" 3-fluorophenmetrazine.

Michael Fawzy1, Wei San Wong-Morrow1, Anthony Beaumont2, Chris K T Farmer3,4.   

Abstract

Until the law in the United Kingdom (UK) changed in May 2016 so called "legal highs" or "new psychoactive substances" were freely available in high street shops across the UK. Following prohibition these drugs are still easily purchased illegally via the internet. We report a case of a patient who self-administered 3-fluorophenmetrazine intravenously with catastrophic consequences. Adverse effects were almost immediate with symptoms of malaise and tachycardia. Two days post administration he was transferred to the intensive therapy unit with acute kidney injury and irreversible four limb ischaemia. He required a period of renal replacement therapy and bilateral lower limb amputation. This case highlights the fact that new psychoactive substances have many unintended adverse effect which have not been previously described. Multiple routes of administration are used by people taking these agents including intravenously. Medical practitioners should always consider ingestion of new psychoactive substances in the differential diagnosis of acutely ill patients.

Entities:  

Keywords:  Acute kidney injury; Limb ischaemia; New psychoactive substance

Year:  2017        PMID: 28711979      PMCID: PMC5694401          DOI: 10.1007/s13730-017-0263-4

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  4 in total

1.  Appetite suppressant drugs: a controlled clinical comparison of benzphetamine, phenmetrazine, d-amphetamine and placebo.

Authors:  A POINDEXTER
Journal:  Curr Ther Res Clin Exp       Date:  1960-08

2.  Test purchase, synthesis and characterization of 3-fluorophenmetrazine (3-FPM) and differentiation from its ortho- and para-substituted isomers.

Authors:  Gavin McLaughlin; Noreen Morris; Pierce V Kavanagh; Geraldine Dowling; John D Power; Brendan Twamley; John O'Brien; Brian Talbot; Harald H Sitte; Simon D Brandt
Journal:  Drug Test Anal       Date:  2016-01-26       Impact factor: 3.345

3.  Adverse events related to the new psychoactive substance 3-fluorophenmetrazine - results from the Swedish STRIDA project.

Authors:  Matilda Bäckberg; Jenny Westerbergh; Olof Beck; Anders Helander
Journal:  Clin Toxicol (Phila)       Date:  2016-08-05       Impact factor: 4.467

4.  Characteristics and outcomes of culture-negative versus culture-positive severe sepsis.

Authors:  Jason Phua; Wang Ngerng; Kay See; Chee Tay; Timothy Kiong; Hui Lim; Mei Chew; Hwee Yip; Adeline Tan; Haji Khalizah; Rolando Capistrano; Kang Lee; Amartya Mukhopadhyay
Journal:  Crit Care       Date:  2013-09-12       Impact factor: 9.097

  4 in total
  3 in total

1.  Novel psychoactive substances: overdose of 3-fluorophenmetrazine (3-FPM) and etizolam in a 33-year-old man.

Authors:  Matthew G K Benesch; Sahar J Iqbal
Journal:  BMJ Case Rep       Date:  2018-06-08

2.  Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho- and meta- positional isomers.

Authors:  Gavin McLaughlin; Michael H Baumann; Pierce V Kavanagh; Noreen Morris; John D Power; Geraldine Dowling; Brendan Twamley; John O'Brien; Gary Hessman; Folker Westphal; Donna Walther; Simon D Brandt
Journal:  Drug Test Anal       Date:  2018-05-23       Impact factor: 3.345

Review 3.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.